Search research articles
Contact Us
Filters
Showing results (281-290 of 416) with videos related to
Page
of 42
Sort By:
The American Journal of Gastroenterology
|
January 26, 2002
Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan
Yoichi Yano, Fumihiko Yamashita, Shuji Sumie, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 22, 2005
Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
Shiro Iino, Eiichi Tomita, Hiromitsu Kumada, et al.
The American Journal of Gastroenterology
|
December 2, 2004
Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy
Hiroaki Nagamatsu, Satoshi Itano, Sakae Nagaoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 17, 2007
Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b(+) HLA-A24(+) patients
Yukari Takao, Akira Yamada, Shigeru Yutani, et al.
International Journal of Molecular Medicine
|
June 11, 2009
Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue
Takato Ueno, Takuji Torimura, Toru Nakamura, et al.
Experimental and Therapeutic Medicine
|
September 15, 2012
Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis
Takato Ueno, Anna Nakamura, Hitomi Nakayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 3, 2004
Prediction of treatment outcome with daily high-dose IFN alpha-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy
Shiro Iino, Eiichi Tomita, Hiromitsu Kumada, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society
|
April 25, 2013
Evaluation of magnifying endoscopy using narrow band imaging using ex vivo bile duct (with video)
Yusuke Ishida, Yoshinobu Okabe, Ryohei Kaji, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 24, 2002
High incidence of extrahepatic manifestations in an HCV hyperendemic area
Yumiko Nagao, Junko Tanaka, Toshio Nakanishi, et al.
American Journal of Hematology
|
July 25, 2003
Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma
Ritsuko Seki, Takashi Okamura, Hironori Koga, et al.
Page
of 42
Search research articles
Search
Showing results (281-290 of 416) with videos related to
Sort By:
Page
of 42
The American Journal of Gastroenterology
|
January 26, 2002
Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan
Yoichi Yano, Fumihiko Yamashita, Shuji Sumie, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 22, 2005
Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
Shiro Iino, Eiichi Tomita, Hiromitsu Kumada, et al.
The American Journal of Gastroenterology
|
December 2, 2004
Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy
Hiroaki Nagamatsu, Satoshi Itano, Sakae Nagaoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 17, 2007
Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b(+) HLA-A24(+) patients
Yukari Takao, Akira Yamada, Shigeru Yutani, et al.
International Journal of Molecular Medicine
|
June 11, 2009
Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue
Takato Ueno, Takuji Torimura, Toru Nakamura, et al.
Experimental and Therapeutic Medicine
|
September 15, 2012
Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis
Takato Ueno, Anna Nakamura, Hitomi Nakayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 3, 2004
Prediction of treatment outcome with daily high-dose IFN alpha-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy
Shiro Iino, Eiichi Tomita, Hiromitsu Kumada, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society
|
April 25, 2013
Evaluation of magnifying endoscopy using narrow band imaging using ex vivo bile duct (with video)
Yusuke Ishida, Yoshinobu Okabe, Ryohei Kaji, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 24, 2002
High incidence of extrahepatic manifestations in an HCV hyperendemic area
Yumiko Nagao, Junko Tanaka, Toshio Nakanishi, et al.
American Journal of Hematology
|
July 25, 2003
Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma
Ritsuko Seki, Takashi Okamura, Hironori Koga, et al.
Page
of 42